racemetirosine has been researched along with Neurilemoma in 1 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, AR | 1 |
| Watanabe, H | 1 |
| Aoki, J | 1 |
| Shinozaki, T | 1 |
| Takagishi, K | 1 |
1 other study available for racemetirosine and Neurilemoma
| Article | Year |
|---|---|
Schwannoma of the extremities: the role of PET in preoperative planning.
Topics: Adult; Aged; alpha-Methyltyrosine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; M | 2001 |